2-(2-Chloro-4-Fluorobenzyl)-3-(4-Fluorophenyl)-7-(Trifluoromethyl)-2H-Indazole 2-(2-氯-4-氟苄基)-3-(4-氟苯基)-7-(三氟甲基)-2H-吲唑
CAS 875787-07-8 MFCD75787078
化学结构图
SMILES:
化学属性
| Mol. Formula | C21H12ClF5N2 |
|---|
别名和识别编码
| Chemical Name | 2-(2-Chloro-4-Fluorobenzyl)-3-(4-Fluorophenyl)-7-(Trifluoromethyl)-2H-Indazole |
|---|---|
| Chemical Name Translation | 2-(2-氯-4-氟苄基)-3-(4-氟苯基)-7-(三氟甲基)-2H-吲唑 |
| Chemicalbook ID | CB22626329 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Giannarelli C, et al. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. Eur Heart J. 2012 Jan;33(2):264-73.
- [3]. Quinet EM, et al. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J Lipid Res. 2009 Dec;50(12):2358-70.
- [4]. DiBlasio-Smith EA, et al. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. J Transl Med. 2008 Oct 16;6:59.
- [1]. Villa GR, et al. An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers. Cancer Cell. 2016 Nov 14;30(5):683-693.
- [1]. Villa GR, et al. An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers. Cancer Cell. 2016 Nov 14;30(5):683-693.
- [2]. Giannarelli C, et al. Synergistic effect of liver X receptor activati
